Hostname: page-component-848d4c4894-75dct Total loading time: 0 Render date: 2024-05-14T02:01:00.081Z Has data issue: false hasContentIssue false
  • English
  • Français

Myopathies

Published online by Cambridge University Press:  17 November 2008

David Hilton-Jones
David Hilton-Jones*
Affiliation:
Radcliffe Infirmary, Oxford, UK
*
David Hilton-Jones David Hilton-Jones, Department of Clinical Neurology, Radcliffe Infirmary, Oxford OX2 6HE, UK.
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Clinical geriatrics
Information
Reviews in Clinical Gerontology , Volume 5 , Issue 3 , August 1995 , pp. 275 - 288
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

1Koenig, M, Hoffman, EP, Bertelson, CJ et al. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in mouse and affected individuals. Cell 1987; 50: 509–17.Google Scholar
2Hoffman, EP, Brown, RH, Kunkel, LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919–28.CrossRefGoogle ScholarPubMed
3Pizzuti, A, Friedman, DL, Caskey, CT. The myotonic dystrophy gene. Arch Neurol 1993; 50: 1173–79.Google Scholar
4Thornton, CA, Griggs, RC, Moxley, RT. Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol 1994; 35: 269–72.CrossRefGoogle ScholarPubMed

Suggested further reading

General textbooks

Brooke, MH. A clinician's view of neuromuscular diseases. Second edition. Baltimore: Williams and Wilkins, 1986.Google Scholar
Engel, AG, Banker, BQ. Myology. New York: McGraw-Hill, 1986.Google Scholar
Walton, J, Karpati, G, Hilton-Jones, D. Disorders of voluntary muscle, sixth edition. Edinburgh: Churchill Livingstone, 1994.Google Scholar

Inflammatory myopathies

Arahata, K, Engel, AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984; 16: 193–208.CrossRefGoogle ScholarPubMed
Arahata, K, Engel, AG. Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann Neurol 1986; 19: 112–25.Google Scholar
Arahata, K, Engel, AG. Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol 1988; 23: 168–73.Google Scholar
Arahata, K, Engel, AG. Monoclonal antibody analysis of mononuclear cells in myopathies. V: Identification and quantitation of T8+ cytotoxic and T8+ suppressor cells. Ann Neurol 1988; 23: 493–99.Google Scholar
Dalakas, MC. Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med 1991; 325: 1487–98.Google Scholar
Dickey, BF, Myers, AR. Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum 1984; 14: 60–76.Google Scholar
Engel, AG, Arahata, K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984; 16: 209–15.CrossRefGoogle ScholarPubMed
Mastaglia, FL, Ojeda, VJ. Inflammatory myopathies: part I. Ann Neurol 1985; 17: 215–27.Google Scholar
Mastaglia, FL, Ojeda, VJ. Inflammatory myopathies: part II. Ann Neurol 1985; 17: 317–23.Google Scholar
Sigurgeirsson, B, Lindelof, B, Edhag, O, Allander, E. Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med 1992; 326: 363–67.CrossRefGoogle ScholarPubMed

Myasthenic syndromes

Mossman, S, Vincent, A, Newsom-Davis, J. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet 1986; i: 116–19.CrossRefGoogle Scholar
Newsom-Davis, J. Myasthenia gravis and related syndromes. In: Walton, J, Karpati, G, Hilton-Jones, D eds. Disorders of voluntary muscle, sixth edition. Edinburgh: Churchill Livingstone, 1994: 761–80.Google Scholar
O'Neill, JH, Murray, NMF, Newsom-Davis, J. The Lambert-Eaton myasthenic syndrome. Brain 1988; 111: 577–96.CrossRefGoogle ScholarPubMed

Toxic myopathies

Argov, Z, Mastaglia, FL. Drug-induced neuromuscular disorders in man. In: Walton, J, Karpati, G, Hilton-Jones, D eds. Disorders of voluntary muscle, sixth edition. Edinburgh: Churchill Livingstone, 1994: 989–1029.Google Scholar
Victor, M. Toxic and nutritional myopathies. In: Engel, AG, Banker, BG eds. Myology. New York: McGraw-Hill, 1986: 1807–42.Google Scholar

Metabolic and endocrine myopathies

Bindoff, LA, Jackson, J, Turnbull, DM. Mitochondrial and lipid storage disorders of muscle. In: Walton, J, Karpati, G, Hilton-Jones, D eds. Disorders of voluntary muscle, sixth edition. Edinburgh: Churchill Livingstone, 1994: 717–42.Google Scholar
Harris, JB, Turnbull, DM eds. Baillière's Clinical Endocrinology and Metabolism, Volume 4, Issue 3, Muscle metabolism. London: Baillière Tindall, 1990.Google Scholar
DiMauro, S, Moraes, CT. Mitochondrial encephalomyo-pathies. Arch Neurol 1993; 50: 1197–208.Google Scholar
Layzer, RB. Neuromuscular manifestations of systemic disease. First edition. Philadelphia: FA Adams, 1985: 79–137.Google Scholar
Moxley, RT. Metabolic and endocrine myopathies. In: Walton, J, Karpati, G, Hilton-Jones, D eds. Disorders of voluntary muscle, sixth edition. Edinburgh: Churchill Livingstone, 1994: 689–716.Google Scholar

Paraneoplastic myopathies

Hilton-Jones, D. Neuromuscular disorders. In: Walton, J, Karpati, G, Hilton-Jones, D eds. Disorders of voluntary muscle, sixth edition. Edinburgh: Churchill-Livingstone, 1994: 967–87.Google Scholar
Layzer, RB. Neuromuscular manifestations of systemic disease. First edition. Philadelphia: FA Adams, 1985: 264–82.Google Scholar
O'Neill, JH, Murray, NMF, Newsom-Davis, J. The Lambert-Eaton myasthenic syndrome. Brain 1988; 111: 577–96.Google Scholar

Ocular myopathies

Tome, FMS, Fardeau, M. Ocular myopathies. In: Engel, AG, Banker, BQ eds. Myology. New York: McGraw-Hill, 1986: 1327–47.Google Scholar